{"nct_id":"NCT03559270","title":"A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis","status":"TERMINATED","status_verified_date":"2022-10","start_date":"2018-06-27","start_date_type":"ACTUAL","primary_completion_date":"2021-10-14","primary_completion_date_type":"ACTUAL","completion_date":"2022-06-13","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["LLY"]}